LianBio (LIANY)
OTCMKTS · Delayed Price · Currency is USD
0.0570
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
LianBio Market Cap
LianBio has a market cap or net worth of $6.17 million as of August 22, 2025. Its market cap has decreased by -82.41% in one year.
Market Cap
6.17M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 6.17M, a decrease of -99.57%. That is a compound annual growth rate of -76.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 6.17M | -78.49% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
| Nov 1, 2021 | 1.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 385.33M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 367.18M |